These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 196331)

  • 1. Correlation between lipid synthesis in tumor cells and their sensitivity to humoral immune attack.
    Schlager SI; Ohanian SH
    Science; 1977 Aug; 197(4305):773-6. PubMed ID: 196331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of antibody-complement-mediated killing of tumor cells by hormones.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1976 Oct; 36(10):3672-7. PubMed ID: 182362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inhibiting DNA, RNA, and protein synthesis of tumor cells on their susceptibility to killing by antibody and complement.
    Schlager SI; Boyle MD; Ohanian SH; Borsos T
    Cancer Res; 1977 May; 37(5):1432-7. PubMed ID: 192450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between the ability of tumor cells to incorporate specific fatty acids and their sensitivity to killing by a specific antibody plus guinea pig complement.
    Schlager SI; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1978 Sep; 61(3):931-4. PubMed ID: 278869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-specific and forssman antigens of guinea-pig hepatoma cells: comparison of tumor cells grown in vivo and in vitro.
    Evans CH; Ohanian SH; Cooney AM
    Int J Cancer; 1975 Mar; 15(3):512-21. PubMed ID: 166937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between the ability of tumor cells to resist humoral immune attack and their ability to synthesize lipid.
    Schlager SI; Ohanian SH; Borsos T
    J Immunol; 1978 Feb; 120(2):463-71. PubMed ID: 202652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapeutic drugs increase killing of tumor cells by antibody and complement.
    Segerling M; Ohanian SH; Borsos T
    Science; 1975 Apr; 188(4183):55-7. PubMed ID: 46622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing effect by metabolic inhibitors on the killing of tumor cells by antibody and complement.
    Segerling M; Ohanian SH; Borsos T
    Cancer Res; 1975 Nov; 35(11 Pt 1):3195-203. PubMed ID: 52404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysis of tumor cells by antibody and complement. III. Lack of correlation between antigen movement and cell lysis.
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1975 Aug; 115(2):473-5. PubMed ID: 50364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of lipids associated with the ability of tumor cells to resist humoral immune attack.
    Schlager SI; Ohanian SH; Borsos T
    J Immunol; 1978 Feb; 120(2):472-80. PubMed ID: 202653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysis of tumor cells by antibody and complement. II. Lack of correlation between amount of C4 and C3 fixed and cell lysis.
    Ohanian SH; Borsos T
    J Immunol; 1975 Apr; 114(4):1292-5. PubMed ID: 163862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of hormone-induced tumor cell resistance to killing by antibody and complement.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1977 Mar; 37(3):765-70. PubMed ID: 189914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of metabolic inhibitors on killing of tumor cells by antibody and complement.
    Segerling M; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1974 Nov; 53(5):1411-3. PubMed ID: 4372384
    [No Abstract]   [Full Text] [Related]  

  • 14. A role for fatty acid composition of complex cellular lipids in the susceptibility of tumor cells to humoral immune killing.
    Schlager SI; Ohanian SH
    J Immunol; 1979 Jul; 123(1):146-52. PubMed ID: 448144
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of metabolic inhibitors on the ability of tumor cells to express antigen and bind complement components C4 and C3.
    Segerling M; Ohanian SH; Borsos T
    Cancer Res; 1975 Nov; 35(11 Pt 1):3204-8. PubMed ID: 52405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of concanavalin A on the killing of tumor cells by antibody and complement.
    Boyle MD; Langone JJ; Ohanian SH; Borsos T
    J Immunol; 1977 May; 118(5):1626-30. PubMed ID: 192797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of the synthesis and release of lipids in tumor cells under attack by antibody and C.
    Schlager SI; Ohanian SH; Borsos T
    J Immunol; 1978 Mar; 120(3):895-901. PubMed ID: 632591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysis of tumor cells by antibody and complement. 1. Lack of correlation between antigen content and lytic susceptibility.
    Ohanian SH; Borsos T; Rapp HJ
    J Natl Cancer Inst; 1973 May; 50(5):1313-20. PubMed ID: 4351395
    [No Abstract]   [Full Text] [Related]  

  • 19. Lysis of tumor cells by antibody and complement. VI. Enhanced killing of enzyme-pretreated tumor cells.
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1976 Mar; 116(3):661-8. PubMed ID: 176270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturally soluble tumor antigens from guinea pig hepatomas: isolation and partial characterization.
    Detrick-Hooks B; Smith HG; Bast RC; Dunkel VC; Borsos T
    J Immunol; 1976 May; 116(5):1324-31. PubMed ID: 178795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.